Sturge-Weber syndrome: soft-tissue and skeletal overgrowth.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 19182685)

Published in J Craniofac Surg on March 01, 2009

Authors

Arin K Greene1, Sarah F Taber, Karen L Ball, Bonnie L Padwa, John B Mulliken

Author Affiliations

1: Department of Plastic and Oral Surgery, Vascular Anomalies Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. arin.greene@childrens.harvard.edu

Articles by these authors

Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet (2012) 3.13

Venous malformations of skeletal muscle. Plast Reconstr Surg (2002) 2.79

Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet (2003) 2.56

Current management of hemangiomas and vascular malformations. Clin Plast Surg (2005) 2.27

Intramuscular capillary-type hemangioma: radiologic-pathologic correlation. Pediatr Radiol (2014) 2.16

Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med (2010) 2.16

Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest (2008) 2.10

RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev (2005) 2.10

Validity and reliability of craniofacial anthropometric measurement of 3D digital photogrammetric images. Cleft Palate Craniofac J (2008) 2.02

Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat (2008) 2.00

Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet (2008) 1.95

Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82

Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A (2005) 1.82

TFAP2A mutations result in branchio-oculo-facial syndrome. Am J Hum Genet (2008) 1.79

Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol (2005) 1.77

Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol (2011) 1.74

Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol (2004) 1.73

Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics (2005) 1.72

Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet (2002) 1.66

Resection of amblyogenic periocular hemangiomas: indications and outcomes. Plast Reconstr Surg (2010) 1.65

The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet (2007) 1.64

Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr (2012) 1.63

Clinical application of curvilinear distraction osteogenesis for correction of mandibular deformities. J Oral Maxillofac Surg (2009) 1.61

Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg (2010) 1.61

Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg (2005) 1.59

Involvement of the basilar coronal ring in unilateral coronal synostosis. Plast Reconstr Surg (2005) 1.52

Endothelial progenitor cells in infantile hemangioma. Blood (2003) 1.50

Maternal vitamin K deficient embryopathy: association with hyperemesis gravidarum and Crohn disease. Am J Med Genet A (2013) 1.46

Robin sequence: a retrospective review of 115 patients. Int J Pediatr Otorhinolaryngol (2006) 1.45

Current surgical management of bilateral cleft lip in North America. Plast Reconstr Surg (2012) 1.44

Gorham-Stout disease and generalized lymphatic anomaly--clinical, radiologic, and histologic differentiation. Skeletal Radiol (2013) 1.44

Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg (2007) 1.43

Speech outcomes following pharyngeal flap in patients with velocardiofacial syndrome. Plast Reconstr Surg (2011) 1.42

Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood (2006) 1.40

The Changing Nasolabial Dimensions following Repair of Unilateral Cleft Lip: An Anthropometric Study in Late Childhood. Plast Reconstr Surg (2016) 1.40

Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet (2008) 1.39

Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg (2011) 1.38

Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol (2003) 1.35

CRISPLD2: a novel NSCLP candidate gene. Hum Mol Genet (2007) 1.32

Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol (2004) 1.32

Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A (2005) 1.28

Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25

IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res (2008) 1.25

Management of parotid hemangioma in 100 children. Plast Reconstr Surg (2004) 1.24

Verrucous hemangioma revisited. Pediatr Dermatol (2006) 1.22

The presentation and management of nasal dermoid: a 30-year experience. Arch Otolaryngol Head Neck Surg (2003) 1.22

The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. Am J Hum Genet (2006) 1.22

Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification. Virchows Arch (2008) 1.22

Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol (2013) 1.19

Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet (2009) 1.17

Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement. Dev Med Child Neurol (2011) 1.16

Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg (2011) 1.15

Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol (2008) 1.14

Resorbable internal splint: an adjunct to primary correction of unilateral cleft lip-nasal deformity. Plast Reconstr Surg (2002) 1.12

Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. Pediatrics (2002) 1.12

CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism. J Thorac Cardiovasc Surg (2010) 1.11

D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol (2005) 1.09

RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat (2013) 1.09

Mandibular deformity in hemifacial microsomia: a reassessment of the Pruzansky and Kaban classification. Plast Reconstr Surg (2014) 1.09

Incidence of cranial asymmetry in healthy newborns. Pediatrics (2002) 1.07

An association between hemifacial microsomia and facial clefting. J Oral Maxillofac Surg (2005) 1.07

Folate pathway and nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol (2010) 1.06

JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol (2011) 1.05

Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop (2014) 1.05

Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells (2015) 1.05

PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol (2012) 1.05

Vasoactive exposures, vascular events, and hemifacial microsomia. Birth Defects Res A Clin Mol Teratol (2004) 1.03

Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet A (2007) 1.03

Palatoplasty outcomes in nonsyndromic patients with cleft palate: a 29-year assessment of one surgeon's experience. J Craniofac Surg (2009) 1.02

Anthropometric analysis of mandibular asymmetry in infants with deformational posterior plagiocephaly. J Oral Maxillofac Surg (2002) 1.02

VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol (2011) 1.01

Association of chromosomal regions 3p21.2, 10p13, and 16p13.3 with nonsyndromic cleft lip and palate. Am J Med Genet A (2004) 1.01

Auricular arteriovenous malformation: evaluation, management, and outcome. Plast Reconstr Surg (2005) 1.01

Risk of vascular anomalies with Down syndrome. Pediatrics (2008) 1.00

Fifty years of the Millard rotation-advancement: looking back and moving forward. Plast Reconstr Surg (2009) 1.00

Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations. Plast Reconstr Surg (2016) 1.00

Locus for susceptibility for familial capillary malformation ('port-wine stain') maps to 5q. Eur J Hum Genet (2002) 0.98

Diprosopus: a unique case and review of the literature. Teratology (2002) 0.97

Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol (2005) 0.97

The role of congenital muscular torticollis in the development of deformational plagiocephaly. Plast Reconstr Surg (2009) 0.97

Demographic and reproductive factors associated with hemifacial microsomia. Cleft Palate Craniofac J (2004) 0.97

Complications associated with cleft lip and palate repair. Oral Maxillofac Surg Clin North Am (2003) 0.97

PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg (2014) 0.96

Expanding the phenotype of craniofrontonasal syndrome: two unrelated boys with EFNB1 mutations and congenital diaphragmatic hernia. Eur J Hum Genet (2006) 0.96

Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet (2003) 0.94

Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis (2010) 0.94

Genomic imprinting of IGF2 is maintained in infantile hemangioma despite its high level of expression. Mol Med (2006) 0.94

Repair of bilateral cleft lip: review, revisions, and reflections. J Craniofac Surg (2003) 0.93

Treatment of unilateral coronal synostosis by endoscopic strip craniectomy or fronto-orbital advancement: Ophthalmologic findings. J AAPOS (2009) 0.93

Nasolabial soft tissue changes after Le Fort I advancement. J Oral Maxillofac Surg (2012) 0.92

Family-based study shows heterogeneity of a susceptibility locus on chromosome 8q24 for nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol (2010) 0.92

Frequency of Le Fort I osteotomy after repaired cleft lip and palate or cleft palate. Cleft Palate Craniofac J (2007) 0.92

Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg (2005) 0.92

Anesthetic concerns of external maxillary distraction osteogenesis. J Craniofac Surg (2004) 0.92

Intracranial anomalies detected by imaging studies in 30 patients with Apert syndrome. Am J Med Genet A (2006) 0.91